258 related articles for article (PubMed ID: 16036093)
21. Parathyroid hormone treatment for osteoporosis.
Cosman F
Curr Opin Endocrinol Diabetes Obes; 2008 Dec; 15(6):495-501. PubMed ID: 18971677
[TBL] [Abstract][Full Text] [Related]
22. Does the combination of alendronate and parathyroid hormone give a greater benefit than either agent alone in osteoporosis?
Doggrell SA
Expert Opin Pharmacother; 2004 Apr; 5(4):955-8. PubMed ID: 15102578
[TBL] [Abstract][Full Text] [Related]
23. [Large clinical trials for osteoporosis].
Meunier PJ
Therapie; 2003; 58(5):415-20. PubMed ID: 14682189
[TBL] [Abstract][Full Text] [Related]
24. The Efficacy of Parathyroid Hormone Analogues in Combination With Bisphosphonates for the Treatment of Osteoporosis: A Meta-Analysis of Randomized Controlled Trials.
Li W; Chen W; Lin Y
Medicine (Baltimore); 2015 Sep; 94(38):e1156. PubMed ID: 26402797
[TBL] [Abstract][Full Text] [Related]
25. The cellular and clinical parameters of anabolic therapy for osteoporosis.
Rosen CJ
Crit Rev Eukaryot Gene Expr; 2003; 13(1):25-38. PubMed ID: 12839095
[TBL] [Abstract][Full Text] [Related]
26. Parathyroid hormone.
Madore GR; Sherman PJ; Lane JM
J Am Acad Orthop Surg; 2004; 12(2):67-71. PubMed ID: 15089079
[No Abstract] [Full Text] [Related]
27. Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk--a meta-analysis.
Vestergaard P; Jorgensen NR; Mosekilde L; Schwarz P
Osteoporos Int; 2007 Jan; 18(1):45-57. PubMed ID: 16951908
[TBL] [Abstract][Full Text] [Related]
28. Combination therapy of anabolic agents and bisphosphonates on bone mineral density in patients with osteoporosis: a meta-analysis of randomised controlled trials.
Lou S; Lv H; Li Z; Zhang L; Tang P
BMJ Open; 2018 Mar; 8(3):e015187. PubMed ID: 29500198
[TBL] [Abstract][Full Text] [Related]
29. Pharmacologic management of osteoporosis.
Aynardi M; Ilyas AM
J Hand Surg Am; 2013 Mar; 38(3):588-92. PubMed ID: 23312206
[No Abstract] [Full Text] [Related]
30. Combination therapy with parathyroid hormone analogs and antiresorptive agents for osteoporosis: a systematic review and meta-analysis of randomized controlled trials.
Lou S; Lv H; Yin P; Li Z; Tang P; Wang Y
Osteoporos Int; 2019 Jan; 30(1):59-70. PubMed ID: 30539271
[TBL] [Abstract][Full Text] [Related]
31. [Parathyroid and bone. Role of parathyroid hormone in the treatment of osteoporosis].
Nakamura T
Clin Calcium; 2007 Dec; 17(12):1823-9. PubMed ID: 18057656
[TBL] [Abstract][Full Text] [Related]
32. Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis.
Bauer DC; Garnero P; Bilezikian JP; Greenspan SL; Ensrud KE; Rosen CJ; Palermo L; Black DM
J Clin Endocrinol Metab; 2006 Apr; 91(4):1370-5. PubMed ID: 16449339
[TBL] [Abstract][Full Text] [Related]
33. New therapeutic targets for osteoporosis.
Anagnostis P; Gkekas NK; Potoupnis M; Kenanidis E; Tsiridis E; Goulis DG
Maturitas; 2019 Feb; 120():1-6. PubMed ID: 30583758
[TBL] [Abstract][Full Text] [Related]
34. Combination of anabolic and antiresorptive agents for the treatment of osteoporosis.
Garcés C; García LE
Maturitas; 2006 Apr; 54(1):47-54. PubMed ID: 16257150
[TBL] [Abstract][Full Text] [Related]
35. Non-response to osteoporosis treatment.
Francis RM
J Br Menopause Soc; 2004 Jun; 10(2):76-80. PubMed ID: 15207030
[TBL] [Abstract][Full Text] [Related]
36. Therapy of male osteoporosis with parathyroid hormone.
Bilezikian JP; Kurland ES
Calcif Tissue Int; 2001 Oct; 69(4):248-51. PubMed ID: 11730261
[TBL] [Abstract][Full Text] [Related]
37. Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use.
Hodsman AB; Bauer DC; Dempster DW; Dian L; Hanley DA; Harris ST; Kendler DL; McClung MR; Miller PD; Olszynski WP; Orwoll E; Yuen CK
Endocr Rev; 2005 Aug; 26(5):688-703. PubMed ID: 15769903
[TBL] [Abstract][Full Text] [Related]
38. Parathyroid hormone as an anabolic skeletal therapy.
Rubin MR; Bilezikian JP
Drugs; 2005; 65(17):2481-98. PubMed ID: 16296873
[TBL] [Abstract][Full Text] [Related]
39. Bisphosphonates for prevention of postmenopausal osteoporosis.
Ravn P
Dan Med Bull; 2002 Feb; 49(1):1-18. PubMed ID: 11894721
[TBL] [Abstract][Full Text] [Related]
40. Combination/sequential therapies for anabolic and antiresorptive skeletal agents for osteoporosis.
Bilezikian JP; Rubin MR
Curr Osteoporos Rep; 2006 Mar; 4(1):5-13. PubMed ID: 16527002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
